Status:
COMPLETED
Tolvaptan Versus Fluid Restriction in SIADH
Lead Sponsor:
University of Erlangen-Nürnberg Medical School
Conditions:
Hyponatremia
Syndrome of Inappropriate ADH (SIADH) Secretion
Eligibility:
All Genders
18+ years
Brief Summary
Context. The relevance of hyponatremia has been acknowledged by guidelines from the United States of America (2013) and Europe (2014). However, treatment recommendations differ due to limited evidence...
Detailed Description
Patients of the Department of Neurosurgery, University of Erlangen-Nuremberg, undergoing surgery for sellar lesions were prospectively included. The study protocol was approved by the local Ethical Co...
Eligibility Criteria
Inclusion
- Informed written consent was given by the participant or the next-of-kin.
Exclusion
- Age below 18 years Pregnancy Tolvaptan intolerance.
Key Trial Info
Start Date :
January 1 2009
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 31 2013
Estimated Enrollment :
334 Patients enrolled
Trial Details
Trial ID
NCT04119206
Start Date
January 1 2009
End Date
December 31 2013
Last Update
October 8 2019
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.